Skip to main content

Prostate and Urologic Cancers

Conducts and supports research on the prevention and early detection of prostate and bladder cancers. Develops and supports prevention trials and evaluation of new agents, surrogate biomarkers, and emerging technologies for identifying premalignant lesions.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Asefa, Mela mela.asefa@nih.gov 240-276-6422	5E328	Program Support Assistant \| Breast and Gynecologic Cancer Program Support Assistant \| Prostate and Urologic Cancer
	House, Margaret, RN, B.S.N. margaret.house@nih.gov 240-276-7047	5E306	Deputy Chief \| Prostate and Urologic Cancer
	Parnes, Howard L., M.D. howard.parnes@nih.gov 240-276-7045	5E302	Chief \| Prostate and Urologic Cancer

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Cantuaria, Guilherme	Northside Hospital Atlanta United States	Georgia NCI Community Oncology Research Program (GA NCORP)	3UG1CA189997-11S1	Vanessa A. White, M.P.H.
Cao, Weidan	Ohio State University United States	Treatment-Related Cardiotoxicity Risk Prediction for Breast Cancer Patients with a Multimodal AI-based System	1R01CA301579-01	Eileen Dimond, R.N., M.S.
Cao, Yin	Washington University United States	PROSPECT-Global Consortium and Risk Factor Discovery	3OT2CA297576-01S1	Asad Umar, D.V.M., Ph.D.
Cao, Shugeng	University Of Hawaii At Hilo United States	Discovery of novel natural TEAD inhibitors for the chemoprevention of liver tumors	5UG3CA290375-02	Altaf Mohammed, Ph.D.
Cao, Yin	Washington University United States	Obesity, sedentary behaviors, and diet quality for prevention and early detection of early-onset colorectal neoplasia	4R37CA246175-06	Asad Umar, D.V.M., Ph.D.
Carlson, Jay W	Ozark Health Ventures, Llc United States	Ozark Health Ventures LLC dba Cancer Research for the Ozarks (CRO)	3UG1CA189822-11S1	Vanessa A. White, M.P.H.
Carson, Tiffany Lashaun	H. Lee Moffitt Cancer Ctr & Res Inst United States	Determining the structural- and functional-level effects of diet-specific interventions on the gut microbiota of a diverse sample of Southern United States adults	5R01CA253219-06	Young Kim, Ph.D.
Castilla, Lucio H.	Univ Of Massachusetts Med Sch Worcester United States	Study of tyrosine kinase inhibitors as preventive therapy in RUNX1-FPD	1U01CA296350-01	Marjorie Perloff, M.D.
Castro, Cesar M	Massachusetts General Hospital United States	Composing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approach	3U01CA279858-03S2	Christos Patriotis, Ph.D., M.Sc.
Caulin, Carlos	University Of Arizona United States	Genetic Alterations That Confer High Risk to Oral Premalignant Lesions	5R01CA274857-04
Caywood, Emi H	Nemours Children'S Hospital, Delaware United States	Nemours NCI Community Oncology Research Program (NCORP)	3UG1CA189958-11S1	Vanessa A. White, M.P.H.
Chak, Amitabh	Case Western Reserve University United States	Pathways of Injury and Repair in Barrett's Carcinogenesis	5P01CA269019-03	Asad Umar, D.V.M., Ph.D.
Chan, Andrew T	Massachusetts General Hospital United States	Precision Prevention Research Program	5R35CA253185-06	Asad Umar, D.V.M., Ph.D.
Chan, Daniel Wanyui	Johns Hopkins University United States	BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs	5U2CCA271895-03	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Chan, Alexandre	University Of California-Irvine United States	Neurotrophic strategy to mitigate chemotherapy-related brain injury	5R01CA276212-03	John Clifford, Ph.D.